Vir Biotechnology Inc VIR:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 11/26/21 EST
35.50quote price arrow down-0.50 (-1.39%)
Volume
396
Close
36.00quote price arrow up+3.98 (+12.43%)
Volume
3,294,802
52 week range
25.31 - 141.01
Loading...
  • Open37.06
  • Day High38.34
  • Day Low35.97
  • Prev Close32.02
  • 52 Week High141.01
  • 52 Week High Date01/27/21
  • 52 Week Low25.31
  • 52 Week Low Date01/04/21

Key Stats

  • Market Cap4.702B
  • Shares Out130.61M
  • 10 Day Average Volume1.00M
  • Dividend-
  • Dividend Yield-
  • Beta-1.4
  • YTD % Change34.43

KEY STATS

  • Open37.06
  • Day High38.34
  • Day Low35.97
  • Prev Close32.02
  • 52 Week High141.01
  • 52 Week High Date01/27/21
  • 52 Week Low25.31
  • 52 Week Low Date01/04/21
  • Market Cap4.702B
  • Shares Out130.61M
  • 10 Day Average Volume1.00M
  • Dividend-
  • Dividend Yield-
  • Beta-1.4
  • YTD % Change34.43

RATIOS/PROFITABILITY

  • EPS (TTM)-0.85
  • P/E (TTM)-42.52
  • Fwd P/E (NTM)-40.13
  • EBITDA (TTM)-288.031M
  • ROE (TTM)-45.71%
  • Revenue (TTM)182.71M
  • Gross Margin (TTM)97.37%
  • Net Margin (TTM)-162.74%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date02/23/2022
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Vir Biotechnology, Inc. is a clinical-stage immunology company focused on treating and preventing serious infectious diseases. It has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid (siRNA), through internal development, collaborations, and acquisitions. Its development pipeline consists of product candidates targeting the coronavirus disease 2019 (COVID-19), hepatitis B virus (HBV), influenza A virus and...
Vicki Sato Ph.D.
Non-Executive Chairman
George Scangos Ph.D.
President
Howard Horn
Chief Financial Officer
Ann Hanly
Chief Technology Officer
Herbert Virgin M.D., Ph.D.
Executive Vice President
Address
499 Illinois St Ste 500
San Francisco, CA
94158-2521
United States

Top Peers

SYMBOLLASTCHG%CHG
APLS
Apellis Pharmaceuticals Inc
43.54-1.47-3.27%
NVTA
Invitae Corp
17.99-0.19-1.05%
ABCL
Abcellera Biologics Inc
13.99-0.45-3.12%
FOLD
Amicus Therapeutics Inc
10.80-0.54-4.76%
ADPT
Adaptive Biotechnologies Corp
28.12-0.08-0.28%